Plasma platinum elimination in a hemodialysis patient treated with cisplatin.

@article{Gorodetsky1995PlasmaPE,
  title={Plasma platinum elimination in a hemodialysis patient treated with cisplatin.},
  author={Raphael Gorodetsky and Akiva Vexler and Y Bar-Khaim and H Biran},
  journal={Therapeutic drug monitoring},
  year={1995},
  volume={17 2},
  pages={203-6}
}
The pharmacokinetics of intravenously administrated cisplatin (CDDP) were studied in a patient with meduloblastoma receiving regular hemodialysis for chronic renal failure. The patient received four CDDP infusions of 25 mg/m2 in two courses and underwent hemodialysis before each treatment and in intervals of 48 h thereafter with blood sampling at the beginning and the end of each hemodialysis. The data obtained were compared with the pharmacokinetic data from follow-up studies of 19 CDDP… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

Administration of gemcitabine and cisplatin in cancer patients with renal failure under hemodialysis.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology • 2013
View 1 Excerpt

Similar Papers

Loading similar papers…